_id
690db562ccc777a4e85d0db5
Ticker
BBNX
Name
Beta Bionics, Inc. Common Stock
Exchange
NASDAQ
Address
11 Hughes, Irvine, CA, United States, 92618
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.betabionics.com
Description
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California.
Last Close
17.94
Volume
169701
Current Price
18.865
Change
0.365
Last Updated
2026-01-20T16:15:57.913Z
Image
data:image/webp;base64,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
Ipo Date
2025-01-30T00:00:00.000Z
Market Cap
814455680
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.03400000000000003
Sentiment Sources
2
Rating
4.2857
Target Price
31.8
Strong Buy
4
Buy
1
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
27253000
Cost Of Revenue
12134000
Gross Profit
15119000
Operating Expenses
32162000
Operating Income
-17043000
Interest Expense
-
Pretax Income
-14209000
Net Income
-14209000
Eps
-0.3256405107520955
Dividends Per Share
-
Shares Outstanding
44024631
Income Tax Expense
-
EBITDA
-13526000
Operating Margin
-62.536234542986094
Total Other Income Expense Net
2834000
Cash
38485000
Short Term Investments
190202000
Receivables
14254000
Inventories
20373000
Total Current Assets
270026000
Property Plant Equipment
14409000
Total Assets
330046000
Payables
4461000
Short Term Debt
1980000
Long Term Debt
-
Total Liabilities
35286000
Equity
294760000
Bs_currency_symbol
USD
Depreciation
683000
Change In Working Capital
317000
Cash From Operations
-8729000
Capital Expenditures
1282000
Cash From Investing
9486000
Cash From Financing
2653000
Net Change In Cash
3410000
Cf_currency_symbol
USD
PE
-
PB
2.792629675634414
ROE
-4.820531958203285
ROA
-4.305157462899111
FCF
-10011000
Fcf Percent
-0.36733570616078964
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
3.5
Growth Investing Score
2
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
27253000
Quarters > 0 > income Statement > cost Of Revenue
12134000
Quarters > 0 > income Statement > gross Profit
15119000
Quarters > 0 > income Statement > operating Expenses
32162000
Quarters > 0 > income Statement > operating Income
-17043000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-14209000
Quarters > 0 > income Statement > net Income
-14209000
Quarters > 0 > income Statement > eps
-0.3256405107520955
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
43634006
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-13526000
Quarters > 0 > income Statement > operating Margin
-62.536234542986094
Quarters > 0 > income Statement > total Other Income Expense Net
2834000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
38485000
Quarters > 0 > balance Sheet > short Term Investments
190202000
Quarters > 0 > balance Sheet > receivables
14254000
Quarters > 0 > balance Sheet > inventories
20373000
Quarters > 0 > balance Sheet > total Current Assets
270026000
Quarters > 0 > balance Sheet > property Plant Equipment
14409000
Quarters > 0 > balance Sheet > total Assets
330046000
Quarters > 0 > balance Sheet > payables
4461000
Quarters > 0 > balance Sheet > short Term Debt
1980000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
35286000
Quarters > 0 > balance Sheet > equity
294760000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-14209000
Quarters > 0 > cash Flow > depreciation
683000
Quarters > 0 > cash Flow > change In Working Capital
317000
Quarters > 0 > cash Flow > cash From Operations
-8729000
Quarters > 0 > cash Flow > capital Expenditures
1282000
Quarters > 0 > cash Flow > cash From Investing
9486000
Quarters > 0 > cash Flow > cash From Financing
2653000
Quarters > 0 > cash Flow > net Change In Cash
3410000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.3256405107520955
Quarters > 0 > ratios > PB
2.792629675634414
Quarters > 0 > ratios > ROE
-4.820531958203285
Quarters > 0 > ratios > ROA
-4.305157462899111
Quarters > 0 > ratios > FCF
-10011000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.36733570616078964
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
23238000
Quarters > 1 > income Statement > cost Of Revenue
10735000
Quarters > 1 > income Statement > gross Profit
12503000
Quarters > 1 > income Statement > operating Expenses
32375000
Quarters > 1 > income Statement > operating Income
-19872000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-16869000
Quarters > 1 > income Statement > net Income
-16869000
Quarters > 1 > income Statement > eps
-0.3887703738584062
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
43390652
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-16216000
Quarters > 1 > income Statement > operating Margin
-85.5151045701007
Quarters > 1 > income Statement > total Other Income Expense Net
3003000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
35075000
Quarters > 1 > balance Sheet > short Term Investments
214645000
Quarters > 1 > balance Sheet > receivables
11395000
Quarters > 1 > balance Sheet > inventories
17323000
Quarters > 1 > balance Sheet > total Current Assets
286075000
Quarters > 1 > balance Sheet > property Plant Equipment
12503000
Quarters > 1 > balance Sheet > total Assets
329971000
Quarters > 1 > balance Sheet > payables
3424000
Quarters > 1 > balance Sheet > short Term Debt
1519000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
28338000
Quarters > 1 > balance Sheet > equity
301633000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-16869000
Quarters > 1 > cash Flow > depreciation
653000
Quarters > 1 > cash Flow > change In Working Capital
-1499000
Quarters > 1 > cash Flow > cash From Operations
-13594000
Quarters > 1 > cash Flow > capital Expenditures
1779000
Quarters > 1 > cash Flow > cash From Investing
6173000
Quarters > 1 > cash Flow > cash From Financing
42000
Quarters > 1 > cash Flow > net Change In Cash
-7379000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.3887703738584062
Quarters > 1 > ratios > PB
2.713776841327043
Quarters > 1 > ratios > ROE
-5.592557843472034
Quarters > 1 > ratios > ROA
-5.112267441684269
Quarters > 1 > ratios > FCF
-15373000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.6615457440399346
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
17639000
Quarters > 2 > income Statement > cost Of Revenue
8668000
Quarters > 2 > income Statement > gross Profit
8971000
Quarters > 2 > income Statement > operating Expenses
27613000
Quarters > 2 > income Statement > operating Income
-18642000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-28656000
Quarters > 2 > income Statement > net Income
-28656000
Quarters > 2 > income Statement > eps
-0.932971366315664
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
30714769
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-18038000
Quarters > 2 > income Statement > operating Margin
-105.68626339361641
Quarters > 2 > income Statement > total Other Income Expense Net
-10014000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
42454000
Quarters > 2 > balance Sheet > short Term Investments
189019000
Quarters > 2 > balance Sheet > receivables
11013000
Quarters > 2 > balance Sheet > inventories
15730000
Quarters > 2 > balance Sheet > total Current Assets
261915000
Quarters > 2 > balance Sheet > property Plant Equipment
11859000
Quarters > 2 > balance Sheet > total Assets
338024000
Quarters > 2 > balance Sheet > payables
3454000
Quarters > 2 > balance Sheet > short Term Debt
1524000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
24272000
Quarters > 2 > balance Sheet > equity
313752000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-28656000
Quarters > 2 > cash Flow > depreciation
604000
Quarters > 2 > cash Flow > change In Working Capital
-6472000
Quarters > 2 > cash Flow > cash From Operations
-19975000
Quarters > 2 > cash Flow > capital Expenditures
333000
Quarters > 2 > cash Flow > cash From Investing
-179122000
Quarters > 2 > cash Flow > cash From Financing
211119000
Quarters > 2 > cash Flow > net Change In Cash
12022000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.932971366315664
Quarters > 2 > ratios > PB
1.8467901947557306
Quarters > 2 > ratios > ROE
-9.133328233764248
Quarters > 2 > ratios > ROA
-8.477504555889523
Quarters > 2 > ratios > FCF
-20308000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.1513124326775894
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
20440000
Quarters > 3 > income Statement > cost Of Revenue
8751000
Quarters > 3 > income Statement > gross Profit
11689000
Quarters > 3 > income Statement > operating Expenses
24726000
Quarters > 3 > income Statement > operating Income
-13037000
Quarters > 3 > income Statement > interest Expense
2000
Quarters > 3 > income Statement > pretax Income
-18108000
Quarters > 3 > income Statement > net Income
-18108000
Quarters > 3 > income Statement > eps
-0.4177274409188343
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
43348840
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-17579000
Quarters > 3 > income Statement > operating Margin
-63.78180039138943
Quarters > 3 > income Statement > total Other Income Expense Net
-5071000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
30432000
Quarters > 3 > balance Sheet > short Term Investments
73143000
Quarters > 3 > balance Sheet > receivables
11996000
Quarters > 3 > balance Sheet > inventories
13320000
Quarters > 3 > balance Sheet > total Current Assets
132923000
Quarters > 3 > balance Sheet > property Plant Equipment
11421000
Quarters > 3 > balance Sheet > total Assets
149645000
Quarters > 3 > balance Sheet > payables
2852000
Quarters > 3 > balance Sheet > short Term Debt
1529000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
73632000
Quarters > 3 > balance Sheet > equity
76013000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-18108000
Quarters > 3 > cash Flow > depreciation
529000
Quarters > 3 > cash Flow > change In Working Capital
-3243000
Quarters > 3 > cash Flow > cash From Operations
-14279000
Quarters > 3 > cash Flow > capital Expenditures
561000
Quarters > 3 > cash Flow > cash From Investing
-29662000
Quarters > 3 > cash Flow > cash From Financing
56892000
Quarters > 3 > cash Flow > net Change In Cash
12951000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.4177274409188343
Quarters > 3 > ratios > PB
10.758368523805137
Quarters > 3 > ratios > ROE
-23.822240932472077
Quarters > 3 > ratios > ROA
-12.100638177018945
Quarters > 3 > ratios > FCF
-14840000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.726027397260274
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
65124000
Annuals > 0 > income Statement > cost Of Revenue
29236000
Annuals > 0 > income Statement > gross Profit
35888000
Annuals > 0 > income Statement > operating Expenses
81139000
Annuals > 0 > income Statement > operating Income
-45251000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-54756000
Annuals > 0 > income Statement > net Income
-54756000
Annuals > 0 > income Statement > eps
-8.602584357360742
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
6365064
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-44100000
Annuals > 0 > income Statement > operating Margin
-69.48436828204656
Annuals > 0 > income Statement > total Other Income Expense Net
-9505000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
30432000
Annuals > 0 > balance Sheet > short Term Investments
73143000
Annuals > 0 > balance Sheet > receivables
11996000
Annuals > 0 > balance Sheet > inventories
13320000
Annuals > 0 > balance Sheet > total Current Assets
132923000
Annuals > 0 > balance Sheet > property Plant Equipment
11421000
Annuals > 0 > balance Sheet > total Assets
149645000
Annuals > 0 > balance Sheet > payables
2852000
Annuals > 0 > balance Sheet > short Term Debt
1529000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
73632000
Annuals > 0 > balance Sheet > equity
76013000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-54756000
Annuals > 0 > cash Flow > depreciation
2283000
Annuals > 0 > cash Flow > change In Working Capital
-12148000
Annuals > 0 > cash Flow > cash From Operations
-48273000
Annuals > 0 > cash Flow > capital Expenditures
3395000
Annuals > 0 > cash Flow > cash From Investing
-3476000
Annuals > 0 > cash Flow > cash From Financing
55615000
Annuals > 0 > cash Flow > net Change In Cash
3866000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-8.602584357360742
Annuals > 0 > ratios > PB
1.5796894262823462
Annuals > 0 > ratios > ROE
-72.0350466367595
Annuals > 0 > ratios > ROA
-36.5905977480036
Annuals > 0 > ratios > FCF
-51668000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.7933787850869112
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
11995000
Annuals > 1 > income Statement > cost Of Revenue
5687000
Annuals > 1 > income Statement > gross Profit
6308000
Annuals > 1 > income Statement > operating Expenses
42158000
Annuals > 1 > income Statement > operating Income
-35850000
Annuals > 1 > income Statement > interest Expense
68000
Annuals > 1 > income Statement > pretax Income
-44099000
Annuals > 1 > income Statement > net Income
-44099000
Annuals > 1 > income Statement > eps
-8.314786476720709
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
5303684
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-34624000
Annuals > 1 > income Statement > operating Margin
-298.8745310546061
Annuals > 1 > income Statement > total Other Income Expense Net
-8249000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
26566000
Annuals > 1 > balance Sheet > short Term Investments
70179000
Annuals > 1 > balance Sheet > receivables
4448000
Annuals > 1 > balance Sheet > inventories
1245000
Annuals > 1 > balance Sheet > total Current Assets
103621000
Annuals > 1 > balance Sheet > property Plant Equipment
6198000
Annuals > 1 > balance Sheet > total Assets
110040000
Annuals > 1 > balance Sheet > payables
1166000
Annuals > 1 > balance Sheet > short Term Debt
1224000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
51432000
Annuals > 1 > balance Sheet > equity
58608000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-44099000
Annuals > 1 > cash Flow > depreciation
2091000
Annuals > 1 > cash Flow > change In Working Capital
-6363000
Annuals > 1 > cash Flow > cash From Operations
-32445000
Annuals > 1 > cash Flow > capital Expenditures
402000
Annuals > 1 > cash Flow > cash From Investing
-69693000
Annuals > 1 > cash Flow > cash From Financing
101029000
Annuals > 1 > cash Flow > net Change In Cash
-1109000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-8.314786476720709
Annuals > 1 > ratios > PB
1.7071730593093093
Annuals > 1 > ratios > ROE
-75.243993993994
Annuals > 1 > ratios > ROA
-40.07542711741185
Annuals > 1 > ratios > FCF
-32847000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.738390996248437
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
179000
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
179000
Annuals > 2 > income Statement > operating Expenses
66023000
Annuals > 2 > income Statement > operating Income
-65844000
Annuals > 2 > income Statement > interest Expense
14000
Annuals > 2 > income Statement > pretax Income
-64751000
Annuals > 2 > income Statement > net Income
-64751000
Annuals > 2 > income Statement > eps
-12.956616116300792
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
4997524
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-63399000
Annuals > 2 > income Statement > operating Margin
-36784.357541899444
Annuals > 2 > income Statement > total Other Income Expense Net
1093000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
27675000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
0
Annuals > 2 > balance Sheet > inventories
0
Annuals > 2 > balance Sheet > total Current Assets
28467000
Annuals > 2 > balance Sheet > property Plant Equipment
6867000
Annuals > 2 > balance Sheet > total Assets
35527000
Annuals > 2 > balance Sheet > payables
430000
Annuals > 2 > balance Sheet > short Term Debt
976000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
22527000
Annuals > 2 > balance Sheet > equity
13000000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-64751000
Annuals > 2 > cash Flow > depreciation
2087000
Annuals > 2 > cash Flow > change In Working Capital
-2790000
Annuals > 2 > cash Flow > cash From Operations
-60208000
Annuals > 2 > cash Flow > capital Expenditures
772000
Annuals > 2 > cash Flow > cash From Investing
-769000
Annuals > 2 > cash Flow > cash From Financing
56782000
Annuals > 2 > cash Flow > net Change In Cash
-4195000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-12.956616116300792
Annuals > 2 > ratios > PB
7.252176173846153
Annuals > 2 > ratios > ROE
-498.0846153846154
Annuals > 2 > ratios > ROA
-182.25856390913953
Annuals > 2 > ratios > FCF
-60980000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-340.6703910614525
Annuals > 2 > health Score
16
Valuation > metrics > PE
-0.3256405107520955
Valuation > metrics > PB
2.792629675634414
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-4.820531958203285
Profitability > metrics > ROA
-5.262085873212209
Profitability > metrics > Net Margin
-0.5213737937107842
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.11971095128239924
Risk > metrics > Interest Coverage
-24.953147877013176
Risk > final Score
-40
Risk > verdict
High
Liquidity > metrics > Current Ratio
41.92299332401801
Liquidity > metrics > Quick Ratio
38.75997515913678
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-62
Prev Risks > 1
53
Prev Risks > 2
-26026
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:27:38.304Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-29
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.33
Earnings History > 0 > eps Estimate
-0.4117
Earnings History > 0 > eps Difference
0.0817
Earnings History > 0 > surprise Percent
19.8445
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.2736
Earnings History > 1 > eps Estimate
-0.4671
Earnings History > 1 > eps Difference
0.1935
Earnings History > 1 > surprise Percent
41.4258
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.93
Earnings History > 2 > eps Estimate
-0.506
Earnings History > 2 > eps Difference
-0.424
Earnings History > 2 > surprise Percent
-83.7945
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-2.72
Earnings History > 3 > eps Estimate
-1.2167
Earnings History > 3 > eps Difference
-1.5033
Earnings History > 3 > surprise Percent
-123.5555
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABeta Bionics (NASDAQ:BBNX) Stock Price Down 4.1% - Here's What Happened MarketBeat
Read more →How does BBNX compare to its peers - Stock Correlation Metrics & High Profit Stock Alerts bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$31.8
Analyst Picks
Strong Buy
4
Buy
1
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Beta Bionics, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.33
EPS Estimate
-0.4117
EPS Difference
0.0817
Surprise Percent
19.8445%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.